InSights Hub

Showing 221 to 230 of 366 (Page 23)

Guidelines + Trials Rundown - Juvenile Arthritis

Advances in Juvenile Arthritis – Guidelines+ Trials Rundown

We’re going to take a look at the ongoing studies and clinical trials specific to juvenile arthritis. The below list was curated by assessing the ongoing Phase 3 trials for juvenile arthritis that are based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that have […]

Read More
Guidelines Side-By-Side Migraine & Headache

A Comparative Analysis of Migraine & Headache Management Guidelines – National Migraine & Headache Awareness Month

National Migraine and Headache Awareness Month, observed in June, is an annual event that highlights the importance of utilizing evidence-based strategies when crafting patient-centered treatment plans for individuals grappling with headaches and migraines. With headaches ranking the 5th most common reason for emergency department visits, it is no surprise that the CDC estimates migraine disorder […]

Read More
ISTH 2024 Recap

ISTH 2024 Conference Recap – Venous Thromboembolism (VTE)

The International Society on Thrombosis and Haemostasis held its annual conference (ISTH 2024) in Bangkok, Thailand from June 22-26th. It is the premier global organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis. During ISTH 2024, groundbreaking research on venous thromboembolism (VTE) was presented, showcasing the latest […]

Read More
Guidelines+ Trials Spotlight - Imfinzi® Muscle-Invasive Bladder Cancer Trial Results NIAGARA

Imfinzi® Muscle-Invasive Bladder Cancer Trial Results NIAGARA – Guidelines+ Trials Spotlight

According to the American Cancer Society, bladder cancer accounts for approximately 4% of all cancers in the United States, making it the fourth most common cancer in men and less common in women. The likelihood of men developing bladder cancer in their lifetime is about 1 in 28, while for women, the chance is about […]

Read More
Guidelines Spotlight - Epilepsy in Women

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication – Guidelines Spotlight

A focused guideline update “Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication” was released by the American Academy of Neurology (AAN), the American Epilepsy Society (AES), and the Society for Maternal-Fetal Medicine (SMFM) on May 15, 2024. The new guideline updates the previous 2009 guideline for “Management Issues for Women with […]

Read More
Guidelines Side-By-Side IBS

Comparing AGA and ACG Guidelines for Irritable Bowel Syndrome (IBS) – Guidelines Side-By-Side

This week’s Guidelines Side-By-Side Series will compare the irritable bowel syndrome (IBS) guidelines from the two prominent GI-related associations in the United States – AGA and ACG. Below is an overview of the three guidelines that will be compared side-by-side. The AGA guidelines, while technically two separate documents, were published together at the same time. […]

Read More
Guidelines+ Journal Rundown Orthopedics

Top Orthopedics and Sports Medicine Articles June 2024 – Guidelines+ Journals

In this post, we will be taking a closer look at some of the most popular orthopedics and sports medicine-related articles recently published across medical journals. Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men-A randomized clinical trial Activity-Dependent Compensation at the Hip and Ankle at 8 Years After the Reconstruction […]

Read More
Guidelines+ Trials Rundown - Gout

Gout in Adults – Guidelines+ Trials Rundown

Today we’re going to look at the ongoing studies and clinical trials specific to gout in adults. The below list was curated by assessing the ongoing Phase 3 trials for gout, specific for adults, and based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that […]

Read More
SVSVAM 2024 Recap

VAM24 Conference Recap – The Latest Research on Aortic Disease

The 2024 Vascular Annual Meeting (VAM24) took place from June 19-22 in Chicago, Illinois, serving as the Society of Vascular Surgery’s (SVS) premier event. This meeting provided a plethora of valuable scientific content tailored to meet the needs of every member of the vascular care team. A key focus of VAM24 was aortic disease, encompassing […]

Read More